TFF Pharmaceuticals, Inc. Common Stock
TFFP
TFFP was delisted on the 12th of December, 2024.
33 hedge funds and large institutions have $3.02M invested in TFF Pharmaceuticals, Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 13 reducing their positions, and 6 closing their positions.
8% less funds holding
Funds holding: 36 → 33 (-3)
37% less capital invested
Capital invested by funds: $4.79M → $3.02M (-$1.78M)
50% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 6
92% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 13
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OP
ORG Partners
Roanoke,
Indiana
|
+$10.6K |
| 2 |
Renaissance Technologies
New York
|
+$10.3K |
| 3 |
Group One Trading
Chicago,
Illinois
|
+$1.02K |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$72 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
-$106K |
| 2 |
Millennium Management
New York
|
-$64.1K |
| 3 |
PCM
Princeton Capital Management
Red Bank,
New Jersey
|
-$44.3K |
| 4 |
GS
Gagnon Securities
New York
|
-$34.6K |
| 5 |
BlackRock
New York
|
-$34.2K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Bank of America
Charlotte,
North Carolina
| $1.59K | -$862 | -60 | -31% |
|
27
Wells Fargo
San Francisco,
California
| $1.29K | – | – | – |
|
28
Morgan Stanley
New York
| $854 | -$115 | -8 | -10% |
|
|
29
Group One Trading
Chicago,
Illinois
| $831 | +$1.02K | +71 | New |
|
|
HPC
30
HM Payson & Co
Portland,
Maine
| $705 | – | – | – |
|
31
Osaic Holdings
Scottsdale,
Arizona
| $470 | – | – | – |
|
|
BCM
32
Bridgeway Capital Management
Houston,
Texas
| – | -$16.3K | -952 | Closed |
|
33
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$8.19K | -570 | Closed |
|
34
Two Sigma Investments
New York
| – | -$7.54K | -440 | Closed |
|
|
VWM
35
Venturi Wealth Management
Austin,
Texas
| – | -$6.95K | -405 | Closed |
|
|
BWP
36
Baldwin Wealth Partners
Marion,
Massachusetts
| – | -$6.85K | -400 | Closed |
|
37
Citadel Advisors
Miami,
Florida
| – | -$891 | -62 | Closed |
|
|
38
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | +$72 | +5 | New |
|
TFFP Hedge Fund Activity: Q2 2023 in Review
33 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in TFF Pharmaceuticals, Inc. Common Stock (TFFP) for Q2 2023, worth a combined $3.02M — down 37% from $4.79M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of TFFP and 3 opened new positions — a net loss of 3 holders — while 13 trimmed existing stakes and 1 added.
The largest buyer was ORG Partners, opening a new position worth an estimated $10.6K. The largest seller was AIGH Capital Management, cutting an estimated $106K.
- 33 institutional investors held TFF Pharmaceuticals, Inc. Common Stock (TFFP) as of Q2 2023, down from 36 in Q1 2023.
- Funds reported $3.02M of TFF Pharmaceuticals, Inc. Common Stock stock for Q2 2023, down 37% quarter-over-quarter.
- 3 funds opened new TFF Pharmaceuticals, Inc. Common Stock positions in Q2 2023 and 6 closed out, a net change of -3 holders.
- The largest TFF Pharmaceuticals, Inc. Common Stock buyer in Q2 2023 was ORG Partners, an estimated $10.6K added.
- The largest TFF Pharmaceuticals, Inc. Common Stock seller in Q2 2023 was AIGH Capital Management, an estimated $106K sold.
Based on aggregated 13F filings for Q2 2023.